Mengis Capital Management, Inc. Eli Lilly & CO Transaction History

Mengis Capital Management, Inc.

$497 Million
Q3 2024

A detailed history of Mengis Capital Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Mengis Capital Management, Inc. holds 7,559 shares of LLY stock, worth $5.92 Million. This represents 1.35% of its overall portfolio holdings.

Number of Shares

7,559

Previous 7,399 2.16%

Holding current value

$5.92 Million

Previous $6.7 Million 0.03%

% of portfolio

1.35%

Previous 1.38%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$772.14 - $960.02 $123,542 - $153,603	160 Added 2.16%	7,559 $6.7 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $54,365 - $68,178	-75 Reduced 1.0%	7,399 $6.7 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $85,869 - $114,880	145 Added 1.98%	7,474 $5.81 Million
Q4 2023 Feb 01, 2024	SELL	$525.19 - $619.13 $10,503 - $12,382	-20 Reduced 0.27%	7,329 $4.27 Million
Q3 2023 Nov 09, 2023	BUY	$434.7 - $599.3 $53,902 - $74,313	124 Added 1.72%	7,349 $3.95 Million
Q2 2023 Aug 08, 2023	BUY	$350.74 - $468.98 $1,753 - $2,344	5 Added 0.07%	7,225 $3.39 Million
Q1 2023 May 05, 2023	BUY	$310.63 - $364.82 $17,705 - $20,794	57 Added 0.8%	7,220 $2.48 Million
Q4 2022 Feb 01, 2023	BUY	$321.55 - $374.67 $1,607 - $1,873	5 Added 0.07%	7,163 $2.62 Million
Q3 2022 Nov 04, 2022	BUY	$296.48 - $337.87 $1,778 - $2,027	6 Added 0.08%	7,158 $2.31 Million
Q2 2022 Jul 19, 2022	BUY	$278.73 - $327.27 $1,672 - $1,963	6 Added 0.08%	7,152 $2.32 Million
Q1 2022 May 02, 2022	BUY	$234.69 - $291.66 $517,960 - $643,693	2,207 Added 44.69%	7,146 $2.05 Million
Q4 2021 Feb 04, 2022	BUY	$224.85 - $279.04 $1,349 - $1,674	6 Added 0.12%	4,939 $1.36 Million
Q3 2021 Nov 03, 2021	BUY	$221.6 - $272.71 $1,551 - $1,908	7 Added 0.14%	4,933 $1.14 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $199,868 - $258,528	1,107 Added 28.99%	4,926 $1.13 Million
Q1 2021 May 07, 2021	BUY	$164.32 - $212.72 $165,634 - $214,421	1,008 Added 35.86%	3,819 $713,000
Q4 2020 Feb 03, 2021	BUY	$130.46 - $172.63 $1,043 - $1,381	8 Added 0.29%	2,811 $474,000
Q3 2020 Oct 29, 2020	BUY	$146.22 - $169.13 $2,485 - $2,875	17 Added 0.61%	2,803 $414,000
Q2 2020 Jul 22, 2020	BUY	$136.42 - $164.18 $1,227 - $1,477	9 Added 0.32%	2,786 $457,000
Q1 2020 May 06, 2020	BUY	$119.05 - $147.35 $330,601 - $409,190	2,777 New	2,777 $385,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $744B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mengis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mengis Capital Management, Inc. with notifications on news.

Account

Mengis Capital Management, Inc. Eli Lilly & CO Transaction History